Browse

Senate Democrats open an inquiry into the Trump administration’s remaking of U.S. vaccine policy, demanding officials produce records by next week.

What’s next for GLP-1 weight loss drugs? Alex Hogan explores on the new episode of STATus Report. Watch now.

Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.